NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2052220073

Registered date:10/08/2022

A multicenter, pivotal study to demonstrate non-inferiority of Cyt-006 compared to Seprafilm in patients with primary rectal cancer and temporal colostomy underwent laparoscopic surgery

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedprimary rectal cancer
Date of first enrollment10/08/2022
Target sample size158
Countries of recruitment
Study typeInterventional
Intervention(s)Application of the anti-adhesion barrier

Outcome(s)

Primary Outcomepresence/absence of adhesion
Secondary OutcomeEfficacy: Severity score of adhesion Range score of adhesion Presence/absence of ileus Success rate of pasting Safety: Adverse event, device failure or malfunction hematologic tests, blood biochemical tests vital signs

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
Gender
Include criteria1) Patients with initial and primary rectal cancer. 2) Patients with cStage 0 to cStage III. 3) Patients who are scheduled to undergo laparoscopic rectal resection and temporal colostomy. 4) Patients who are scheduled to undergo the closure of artificial anus at 8 to 48 weeks after initial surgery.
Exclude criteriaPre-operation: 1) Patients who are scheduled to undergo open abdominal surgery. 2) Patients who had a history of intraperitoneal surgery except for appendicitis, Caesarean section, or laparoscopic cholecystectomy. 3) Patients who are scheduled to remove specimens from the site other than the midline incision (except in the case of robotic surgery). 4) Patients whose performance Status >=3. 5) Patients with 35 or higher of BMI. During Operation: 1) Patients who need to undergo open abdominal surgery during laparoscopic procedure. 2) Patients who did not have a temporary colostomy. 3) Patients whose specimen was removed from a site other than the midline wound (except in the case of robotic surgery). 4) Patients who underwent colostomy at the umbilical site

Related Information

Contact

Public contact
Name Yoshihiro Horii
Address 1-1-1 Otemachi, Chiyoda-ku, Tokyo Tokyo Japan 100-0004
Telephone +81-3-6860-5712
E-mail cyt-006-01@cytori-jp.com
Affiliation Cytori Therapeutics K.K.
Scientific contact
Name Yoshihiro Horii
Address 1-1-1 Otemachi, Chiyoda-ku, Tokyo Tokyo Japan 100-0004
Telephone +81-3-6860-5712
E-mail cyt-006-01@cytori-jp.com
Affiliation Cytori Therapeutics K.K.